封面
市场调查报告书
商品编码
1390431

2023-2028 年按手术、产品、最终用户和地区分類的神经修復和再生市场报告

Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028

出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球神经修復与再生市场规模达77亿美元。展望未来, IMARC Group预计到2028年市场规模将达到148亿美元,2022-2028年复合年增长率(CAGR)为11.51%。

神经修復和再生(NRaR)是指用于治疗神经损伤的神经组织工程过程。它促进新神经元、神经胶质细胞、髓鞘、轴突和突触的再生。它还有助于在神经损伤后恢復神经的正常功能,神经损伤通常是由压力、钝性创伤、神经拉伸或切割引起的。 NRaR 涉及生物材料和各种神经刺激和神经调节设备的使用。生物材料包括神经导管、神经保护器、神经包裹物和神经连接器。它们用于直接神经病变、神经移植、干细胞治疗以及经皮、经颅磁、脊髓、深部脑、骶神经和迷走神经刺激。

神经修復与再生市场趋势:

阿兹海默症、帕金森氏症、肌萎缩侧索硬化症、多发性硬化症和多系统萎缩症等慢性神经系统疾病的盛行率不断增加,是推动市场成长的关键因素之一。此外,老年人口的增加(更容易患此类疾病)以及神经损伤病例的不断增加都推动了市场的成长。全球各地的医院、门诊手术中心 (ASC) 和其他医疗机构正在提供新颖的 NRaR 解决方案,以及时诊断和治疗神经系统疾病。此外,干细胞治疗的各种技术进步和创新神经调节装置的开发也起到了其他生长诱导因素的作用。内源性干细胞广泛应用于神经发生、神经修復和外源性神经干细胞移植,以有效修復和取代中枢神经系统受损组织。其他因素,包括大众医疗保健支出的增加,以及医疗基础设施的显着改善,特别是在发展中经济体,预计将推动市场成长。

本报告回答的关键问题

  • 2022年全球神经修復再生市场规模有多大?
  • 2023-2028年全球神经修復和再生市场的预期成长率是多少?
  • 推动全球神经修復和再生市场的关键因素是什么?
  • COVID-19 对全球神经修復和再生市场有何影响?
  • 基于手术的全球神经修復和再生市场的分化是什么?
  • 基于该产品的全球神经修復和再生市场的细分情况如何?
  • 基于最终用户的全球神经修復和再生市场的细分是什么?
  • 全球神经修復与再生市场的关键区域有哪些?
  • 全球神经修復和再生市场的主要参与者/公司有哪些?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球神经修復与再生市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:透过手术进行市场细分

  • 直接神经修復/神经缝合术
    • 市场走向
    • 市场预测
  • 神经移植
    • 市场走向
    • 市场预测
  • 干细胞治疗
    • 市场走向
    • 市场预测
  • 神经刺激与神经调节手术
    • 市场走向
    • 市场预测

第 7 章:按产品分類的市场区隔

  • 生物材料
    • 市场走向
    • 市场预测
  • 神经刺激和神经调节设备
    • 市场走向
    • 关键环节
      • 脊髓刺激装置
      • 深部脑部刺激装置
      • 荐神经刺激装置
      • 迷走神经刺激装置
      • 胃电刺激装置
    • 市场预测

第 8 章:最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测

第 9 章:按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章:价格分析

第14章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Alafair Biosciences Inc.
    • AxoGen Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Collagen Matrix Inc.
    • Integra Lifesciences Corporation
    • Medtronic plc
    • Polyganics BV
    • Soterix Medical Inc.
    • Stryker Corporation
    • Synapse Biomedical Inc.
Product Code: SR112023A4159

Abstract

The global nerve repair and regeneration market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.51% during 2022-2028.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.

Nerve Repair and Regeneration Market Trends:

The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nerve repair and regeneration market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on surgery, product and end user.

Breakup by Surgery:

Direct Nerve Repair/Neurorrhaphy

Nerve Grafting

Stem Cell Therapy

Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

Biomaterial

Neurostimulation and Neuromodulation Devices

Spinal Cord Stimulation Devices

Deep Brain Stimulation Devices

Sacral Nerve Stimulation Devices

Vagus Nerve Stimulation Devices

Gastric Electric Stimulation Devices

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alafair Biosciences Inc., AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Collagen Matrix Inc., Integra Lifesciences Corporation, Medtronic plc, Polyganics BV, Soterix Medical Inc., Stryker Corporation and Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global nerve repair and regeneration market in 2022?
  • 2. What is the expected growth rate of the global nerve repair and regeneration market during 2023-2028?
  • 3. What are the key factors driving the global nerve repair and regeneration market?
  • 4. What has been the impact of COVID-19 on the global nerve repair and regeneration market?
  • 5. What is the breakup of the global nerve repair and regeneration market based on the surgery?
  • 6. What is the breakup of the global nerve repair and regeneration market based on the product?
  • 7. What is the breakup of the global nerve repair and regeneration market based on the end user?
  • 8. What are the key regions in the global nerve repair and regeneration market?
  • 9. Who are the key players/companies in the global nerve repair and regeneration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nerve Repair and Regeneration Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Surgery

  • 6.1 Direct Nerve Repair/Neurorrhaphy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Nerve Grafting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Stem Cell Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Neurostimulation and Neuromodulation Surgeries
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurostimulation and Neuromodulation Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Spinal Cord Stimulation Devices
      • 7.2.2.2 Deep Brain Stimulation Devices
      • 7.2.2.3 Sacral Nerve Stimulation Devices
      • 7.2.2.4 Vagus Nerve Stimulation Devices
      • 7.2.2.5 Gastric Electric Stimulation Devices
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alafair Biosciences Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AxoGen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Collagen Matrix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integra Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Polyganics BV
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Soterix Medical Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Synapse Biomedical Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nerve Repair and Regeneration Market: Major Drivers and Challenges
  • Figure 2: Global: Nerve Repair and Regeneration Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nerve Repair and Regeneration Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nerve Repair and Regeneration Market: Breakup by Surgery (in %), 2022
  • Figure 5: Global: Nerve Repair and Regeneration Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Nerve Repair and Regeneration Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Nerve Repair and Regeneration Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nerve Repair and Regeneration (Nerve Grafting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nerve Repair and Regeneration (Nerve Grafting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nerve Repair and Regeneration (Biomaterial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nerve Repair and Regeneration (Biomaterial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Nerve Repair and Regeneration Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Nerve Repair and Regeneration Industry: SWOT Analysis
  • Figure 74: Global: Nerve Repair and Regeneration Industry: Value Chain Analysis
  • Figure 75: Global: Nerve Repair and Regeneration Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nerve Repair and Regeneration Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Surgery (in Million US$), 2023-2028
  • Table 3: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Nerve Repair and Regeneration Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nerve Repair and Regeneration Market: Competitive Structure
  • Table 7: Global: Nerve Repair and Regeneration Market: Key Players